Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $13.97
• Market Cap: $1.90B
• P/E Ratio: 25.77
• EPS: $0.56
• 52-Week High: $16.54
• 52-Week Low: $6.83

Market Sentiment

Aurinia Pharmaceuticals Inc currently has a Bullish sentiment score of 0.33.

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Aurinia Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does AUPH pay dividends?

Aurinia Pharmaceuticals Inc (AUPH) does not currently pay a regular dividend.

What is AUPH's P/E ratio?

Aurinia Pharmaceuticals Inc has a price-to-earnings (P/E) ratio of 25.77.

What is AUPH's market cap?

Aurinia Pharmaceuticals Inc (AUPH) has a market capitalization of $1.90B with a current stock price of $13.97.